Pentwater Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Pentwater Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,102,104	Closed	-$456M	–	422
2021 Q1	$456M	Buy	+2,102,104	New	+$395M	4.35%	7

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Pentwater Capital Management's GWPH Position: Q2 2021 in Review

Pentwater Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,102,104 shares — an estimated $456M sold.

Pentwater Capital Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $456M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Pentwater Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Pentwater Capital Management sold 2,102,104 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $456M.
Pentwater Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Pentwater Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $456M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.